A型肉毒杆菌毒素注射治疗盆底功能障碍。

IF 3.3 2区 医学 Q1 OBSTETRICS & GYNECOLOGY
Gabrielle T Whitmore, Jenny Tam, Megan Orlando
{"title":"A型肉毒杆菌毒素注射治疗盆底功能障碍。","authors":"Gabrielle T Whitmore, Jenny Tam, Megan Orlando","doi":"10.1016/j.jmig.2025.07.005","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To review the current literature surrounding onabotulinum toxin A injections for patients with pelvic floor dysfunction and to demonstrate how to perform these injections.</p><p><strong>Setting: </strong>Academic tertiary care hospital PARTICIPANTS: It is estimated that about 50-90% of patients with chronic pelvic pain have pain that originates from myofascial sources, including the pelvic floor muscles. In patients with pelvic floor dysfunction, management consists of pelvic floor physical therapy with the addition of pelvic floor trigger point injections with a local anesthetic as needed. We offer onabotulinum toxin A to individuals who require long-term repeat trigger point injections, have barriers to accessing monthly injections, or show no durable improvement.</p><p><strong>Intervention: </strong>We demonstrate a comprehensive pelvic floor exam and techniques for administration of onabotulinum toxin A into pelvic floor muscles in individuals with pelvic floor dysfunction, as well as a demonstration on a live patient. We perform an exam while the patient is awake, either in clinic or at the time of the procedure, and examine the pubococcygeus, iliococcygeus, and obturator internus muscles to assess for hypertonicity and tenderness to palpation. Once sedation is initiated, 200 units of onabotulinum toxin A is then reconstituted with 20 mL of normal saline. The pudendal nerve kit allows for 1cm depth of penetration with the needle. Approximately 1-2 mL of onabotulinumtoxin A are injected sequentially in multiple locations along the above-mentioned pelvic floor muscles. Medication effects may last up to 3-6 months, with a reduction in pain scores starting at 6 weeks and lasting through 12 weeks based on published literature. Adverse effects may include constipation, urinary incontinence, urinary tract infections, fecal incontinence, or urinary retention.</p><p><strong>Conclusions: </strong>Onabotulinumtoxin A may be helpful in patients with refractory pelvic floor dysfunction. We demonstrate how to perform these injections with a safe and reproducible technique.</p>","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Onabotulinumtoxin A Injections for patients with pelvic floor dysfunction.\",\"authors\":\"Gabrielle T Whitmore, Jenny Tam, Megan Orlando\",\"doi\":\"10.1016/j.jmig.2025.07.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To review the current literature surrounding onabotulinum toxin A injections for patients with pelvic floor dysfunction and to demonstrate how to perform these injections.</p><p><strong>Setting: </strong>Academic tertiary care hospital PARTICIPANTS: It is estimated that about 50-90% of patients with chronic pelvic pain have pain that originates from myofascial sources, including the pelvic floor muscles. In patients with pelvic floor dysfunction, management consists of pelvic floor physical therapy with the addition of pelvic floor trigger point injections with a local anesthetic as needed. We offer onabotulinum toxin A to individuals who require long-term repeat trigger point injections, have barriers to accessing monthly injections, or show no durable improvement.</p><p><strong>Intervention: </strong>We demonstrate a comprehensive pelvic floor exam and techniques for administration of onabotulinum toxin A into pelvic floor muscles in individuals with pelvic floor dysfunction, as well as a demonstration on a live patient. We perform an exam while the patient is awake, either in clinic or at the time of the procedure, and examine the pubococcygeus, iliococcygeus, and obturator internus muscles to assess for hypertonicity and tenderness to palpation. Once sedation is initiated, 200 units of onabotulinum toxin A is then reconstituted with 20 mL of normal saline. The pudendal nerve kit allows for 1cm depth of penetration with the needle. Approximately 1-2 mL of onabotulinumtoxin A are injected sequentially in multiple locations along the above-mentioned pelvic floor muscles. Medication effects may last up to 3-6 months, with a reduction in pain scores starting at 6 weeks and lasting through 12 weeks based on published literature. Adverse effects may include constipation, urinary incontinence, urinary tract infections, fecal incontinence, or urinary retention.</p><p><strong>Conclusions: </strong>Onabotulinumtoxin A may be helpful in patients with refractory pelvic floor dysfunction. We demonstrate how to perform these injections with a safe and reproducible technique.</p>\",\"PeriodicalId\":16397,\"journal\":{\"name\":\"Journal of minimally invasive gynecology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-07-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of minimally invasive gynecology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jmig.2025.07.005\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of minimally invasive gynecology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jmig.2025.07.005","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:回顾目前有关注射A型肉毒杆菌毒素治疗盆底功能障碍的文献,并说明如何进行注射。参与者:据估计,大约50-90%的慢性盆腔疼痛患者的疼痛来源于肌筋膜,包括盆底肌肉。对于盆底功能障碍患者,治疗包括盆底物理治疗,并根据需要在局部麻醉下进行盆底触发点注射。我们为需要长期重复触发点注射的个体提供肉毒杆菌毒素A,有获得每月注射的障碍,或没有持久改善。干预:我们展示了一个全面的盆底检查和在盆底功能障碍患者的盆底肌肉中施用肉毒杆菌毒素a的技术,以及一个活体患者的演示。我们在病人清醒时进行检查,无论是在诊所还是在手术时,检查耻骨尾骨肌、髂尾骨肌和闭孔内肌,以评估触诊时的高张力和压痛。一旦开始镇静,200单位肉毒杆菌毒素A再与20毫升生理盐水混合。阴部神经套件允许针头插入1cm深度。沿着上述盆底肌肉的多个部位依次注射约1- 2ml肉毒杆菌毒素A。根据已发表的文献,药物效果可能持续3-6个月,疼痛评分从6周开始减少,持续12周。不良反应可能包括便秘、尿失禁、尿路感染、大便失禁或尿潴留。结论:肉毒杆菌毒素A可能对难治性盆底功能障碍患者有帮助。我们演示了如何使用安全和可重复的技术进行这些注射。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Onabotulinumtoxin A Injections for patients with pelvic floor dysfunction.

Objective: To review the current literature surrounding onabotulinum toxin A injections for patients with pelvic floor dysfunction and to demonstrate how to perform these injections.

Setting: Academic tertiary care hospital PARTICIPANTS: It is estimated that about 50-90% of patients with chronic pelvic pain have pain that originates from myofascial sources, including the pelvic floor muscles. In patients with pelvic floor dysfunction, management consists of pelvic floor physical therapy with the addition of pelvic floor trigger point injections with a local anesthetic as needed. We offer onabotulinum toxin A to individuals who require long-term repeat trigger point injections, have barriers to accessing monthly injections, or show no durable improvement.

Intervention: We demonstrate a comprehensive pelvic floor exam and techniques for administration of onabotulinum toxin A into pelvic floor muscles in individuals with pelvic floor dysfunction, as well as a demonstration on a live patient. We perform an exam while the patient is awake, either in clinic or at the time of the procedure, and examine the pubococcygeus, iliococcygeus, and obturator internus muscles to assess for hypertonicity and tenderness to palpation. Once sedation is initiated, 200 units of onabotulinum toxin A is then reconstituted with 20 mL of normal saline. The pudendal nerve kit allows for 1cm depth of penetration with the needle. Approximately 1-2 mL of onabotulinumtoxin A are injected sequentially in multiple locations along the above-mentioned pelvic floor muscles. Medication effects may last up to 3-6 months, with a reduction in pain scores starting at 6 weeks and lasting through 12 weeks based on published literature. Adverse effects may include constipation, urinary incontinence, urinary tract infections, fecal incontinence, or urinary retention.

Conclusions: Onabotulinumtoxin A may be helpful in patients with refractory pelvic floor dysfunction. We demonstrate how to perform these injections with a safe and reproducible technique.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.00
自引率
7.30%
发文量
272
审稿时长
37 days
期刊介绍: The Journal of Minimally Invasive Gynecology, formerly titled The Journal of the American Association of Gynecologic Laparoscopists, is an international clinical forum for the exchange and dissemination of ideas, findings and techniques relevant to gynecologic endoscopy and other minimally invasive procedures. The Journal, which presents research, clinical opinions and case reports from the brightest minds in gynecologic surgery, is an authoritative source informing practicing physicians of the latest, cutting-edge developments occurring in this emerging field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信